3/13/2026

Align Partners Presses DB Insurance on Governance, Shareholder Returns

Korea Times (03/13/26) Ji-hye, Jun

Align Partners Capital Management has ramped up pressure on DB Insurance (KRX: 005830) over shareholder value concerns by sending a second open letter to the insurer’s board, the fund said Friday. In the letter, issued Thursday in response to DB Insurance’s first shareholder communication on March 5, Align Partners urged the company to take stronger measures to enhance shareholder value and presented additional views on corporate governance reforms and shareholder return policies. The investor called for several changes, including adopting a management strategy based on return on required capital, strengthening shareholder return policies, improving internal transactions with group IT affiliate DB Inc., shifting to a joint trademark ownership structure, overhauling the executive compensation system, and reinforcing board independence. Align also raised new concerns regarding DB Insurance’s acquisition of U.S. insurer Fortegra. In September last year, DB Insurance signed a $1.65 billion deal to acquire Fortegra, the largest overseas takeover by a Korean insurer to date. The fund questioned the consistency of the company’s position, pointing out that while DB Insurance has taken a cautious stance on expanding shareholder payouts citing credit rating stability, it is simultaneously pursuing a large-scale acquisition despite Standard & Poor’s indicating that the deal could weigh on its credit rating. As part of its inquiry, Align requested detailed explanations about aspects of the Fortegra transaction, including the valuation basis and expected internal rate of return. Align acknowledged the insurer’s willingness to engage with shareholders, noting that management and the board had reviewed the proposals individually and responded within the designated timeframe, a move the fund said demonstrates a degree of openness to shareholder dialogue. Regarding Align’s letters, a DB Insurance official said the firm’s risk management framework is designed around efficiency and functions similarly to a return on required capital model. “We also recently decided to cancel 5.6% of our treasury shares acquired to boost shareholder value. We plan to continue reviewing and implementing further shareholder return measures, including complying with new treasury share cancellation requirements under the revised Commercial Act,” the official said. In an earlier letter to shareholders, DB Insurance CEO Jeong Jong-pyo stated, “The insurance industry must balance public responsibility, long-term risk management and the pursuit of shareholder value. We aim to strengthen shareholder trust through profitability-centered growth and more transparent corporate governance.”

Read the article

3/13/2026

Delivery Hero Investor Aspex Calls on CEO to Step Up Turnaround or Face Ouster

Reuters (03/13/26) Steitz, Christoph; Hübner, Alexander

A top Delivery Hero (DHER.DE) shareholder has threatened to push for a change of leadership unless the German online takeaway food group makes fast progress in an ongoing strategic review. Aspex Management said in a letter addressed to Delivery Hero CEO Niklas Oestberg, which was seen by Reuters, that there had been little progress and warned of further value destruction if not enough is done by the company. Hong Kong-based Aspex's comments add to pressure on Delivery Hero's management, which announced in December it would reassess its capital allocation and some country operations. Aspex said it doubted Delivery Hero was the best owner for selected businesses in Asia, the Middle East and Latin America, and that unless there was progress soon, it would "assess all legal courses of action available." These included "initiating steps that aim at ultimately changing the leadership of the company," it added. Oestberg said in a statement in response to the letter that the management board and non-executive supervisory board were "fully aligned" on the ongoing strategic review. "A number of processes and/or negotiations are currently being conducted and need to be handled with due care," the CEO added. He said the share price performance did not accurately reflect what has been achieved, and that management was working diligently to improve profitability and operational performance. In its letter, Aspex said the group was less profitable than rivals Uber (UBER.N), Grab (GRAB.O), Doordash (DASH.O), and Meituan (3690.HK). "Our expectation is that you will identify all those assets where Delivery Hero is not the best owner and operator, and the sale of such assets generates higher value for the company and for its shareholders ... than Delivery Hero continuing to operate such businesses," Aspex said. The sale of individual country divisions or minority holdings would not "constitute a believable and acceptable" outcome of the review, Aspex added. Aspex, Delivery Hero's third-largest investor with a 9.2% stake worth 474 million euros ($542 million), has been on the German company's shareholder register since 2020. The company attracted another investor's attention two years ago amid shareholder concerns about the group's debt and ability to generate enough cash from operations. The founder of investor Sachem Head Capital Management won a seat on the food delivery group's supervisory board in 2024.

Read the article

3/12/2026

Align Partners Commits to Responsible Activism for Minority Shareholders

Korea Times (03/12/26) Whan-woo, Yi

Align Partners founder and CEO Lee Changhwan underscores the firm’s long-term commitment to strengthening minority shareholders’ rights as a homegrown hedge fund, reflecting the growing wave of shareholder activism in Korea’s stock market. This wave is gaining momentum in line with President Lee Jae Myung’s investor-friendly policies, with investors increasingly seeking to influence corporate decisions and governance, often by pressing management to adopt changes that enhance shareholder value. Yet, it has drawn mixed reactions — welcomed by those who see it as progress, but met with caution by those recalling some foreign hedge funds criticized for prioritizing quick, speculative gains over broader shareholder value. “Under the circumstances, I would like to stress that Align Partners naturally pursues long-term, responsible investments, unlike foreign hedge funds that tend to view Korea as just one market among many,” Lee said in an interview with The Korea Times at the company’s office in Seoul’s financial district of Yeouido, Wednesday. Backing up his argument, the CEO said Align Partners is “not inherently virtuous, but circumstances make it inevitable,” stressing compliance with local rules as a licensed asset manager registered under the Financial Services Commission and oversight by the Financial Supervisory Service. At the same time, he noted the demanding nature of long term commitment in Korea, where many listed companies have controlling shareholders with stakes exceeding 10 percent — a rare trait compared with markets like the United States or Japan. “Because of this ownership structure, it is not easy to carry out challenging initiatives with persistence over a long period. But regardless of such difficulties, I sincerely hope our actions will stand as positive examples contributing to the development of the capital market,” Lee said. “In this respect, there can be differences in how we operate compared with foreign funds.” Lee’s remarks came as Align Partners has emerged as a pioneering force among Korea-origin hedge funds, with assets under management reaching $1 billion in less than five years since its founding in September 2021. Before launching Align Partners, Lee worked at Goldman Sachs (GS) and KKR (KKR). Since its founding, it has executed shareholder activism campaigns across a range of high-profile companies, including K-pop powerhouse SM Entertainment (KOSDAQ: 041510), leading financial groups such as KB (KB), Shinhan (SHG), Hana (BKK: HANA), and Woori (NYSE: WF), as well as construction equipment manufacturer Doosan Bobcat (KRX: 241560). The company focuses on exploring opportunities arising from the “Korea discount,” a chronic undervaluation of Korean stocks that the president pledged to address after taking office in June 2025. The CEO welcomed the government’s capital market reform drive, noting three rounds of revisions to the Commercial Act aimed at enhancing corporate governance transparency, boosting shareholder returns and reinforcing the fiduciary responsibility of board members, among other measures. “These measures are something that should have existed naturally, but implementing the parliamentary amendments was a lengthy process and that is why the reform carries real significance,” he said. Asked whether the “Korea discount” has been resolved, Lee replied, “The discount phenomenon is starting to ease slightly, amid growing expectations and interest that corporate behavior will change.” The CEO noted that foreign capital, in particular, is “showing unprecedented levels of interest in Korea” and encouraged greater participation, highlighting that roughly 30 percent of Align Partners' investors are from abroad, mostly U.S. institutional investors. “I believe we are still in the early stages of capital market reform,” he said. “With numerous investment opportunities stemming from corporate governance improvements and restructuring across the broader financial landscape, I would suggest that now is the time to pay close attention to the Korean market.” Regarding the benchmark KOSPI surpassing milestones of 5,000 and even 6,000 points earlier this year, the CEO forecast that the main index is “still far from even halfway through its reform-driven growth cycle.” He referred to the case of Japan's Nikkei, which rose nearly seven- to eightfold over more than a decade of reform, saying, “Much of that sustained growth was driven by governance improvements.” Lee forecast that although the Iran conflict is weighing on the market and caution is warranted, governance reform still has “ample room to influence the stock cycle alongside external factors,” underscoring its potential to strengthen investor confidence and shape longer term market dynamics. To accelerate governance reform, the CEO emphasized three priorities. First, boards must change their behavior to honor shareholder rights and comply with measures such as the 3 percent rule, which limits dominant shareholders to just 3 percent of voting power when electing audit committee members. Secondly, corporate culture must move beyond the entrenched “owner” mindset and recognize that listed companies are collectively owned by all shareholders. Lastly, strong legal precedents should anchor fiduciary responsibilities, giving corporate law the weight of a constitutional principle within the business sphere. For companies in Align Partners' portfolios, the CEO said the firm has submitted shareholder proposals to six firms — DB Insurance (KRX: 005830), Coway (KRX: 021240), Gabia (KOSDAQ: 079940), Dentium (KRX: 145720), SoluM (KRX: 248070), and A Plus Asset Advisor (KRX: 244920)— all of which have general meetings of shareholders scheduled this month. DB Insurance will hold its meeting on March 20, while the others are scheduled to convene through the end of March. In particular, Align Partners is in a dispute with IT infrastructure and cloud services company Gabia, having filed an injunction to add a "say-on-pay" advisory shareholder proposal agenda at the general meeting on March 26. An advisory shareholder proposal, even if passed at a general meeting, is nonbinding — it cannot legally compel the board, but it signals shareholder sentiment, applies reputational pressure and can influence future governance practices.

Read the article

3/12/2026

Integer Appoints Two Directors in Cooperation With Irenic

Investing.com (03/12/26)

Integer Holdings Corporation (NYSE: ITGR) announced today the appointment of two independent directors to its board as part of a cooperation agreement with Irenic Capital Management, LP. James Flanagan, former Chief Operating Officer of PwC, and Aaron Kapito, a Partner at Politan Capital Management, have joined the board. The appointments are based on a press release statement from the company. Flanagan served as PwC’s COO from 2014 to 2021 and previously led the firm’s U.S. Financial Services Practice. He holds a B.S. in Accounting from Long Island University. Kapito co-founded Politan Capital Management in 2021 and previously worked at Lion Point Capital and Elliott Management. He earned a B.S. in Economics from the Wharton School and an M.B.A. from Harvard Business School. Under the cooperation agreement, Irenic agreed to customary standstill, voting, and confidentiality provisions. The full agreement will be filed with the Securities and Exchange Commission. Two existing directors will not stand for re-election at the company’s annual stockholder meeting, consistent with the board’s succession process. Integer’s CEO Payman Khales stated the company expects organic sales growth to return to market levels during 2026 and above-market levels in 2027. The company posted revenue of $1.85 billion over the last twelve months with analysts forecasting earnings per share of $6.51 for fiscal 2026. For deeper insights into Integer’s growth trajectory and financial health, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro for this and 1,400+ other U.S. equities. Adam Katz, Co-Founder and Chief Investment Officer of Irenic Capital Management, said the firm invested in Integer because it believes the company is positioned to capitalize on growth opportunities. Integer is a medical device contract development and manufacturing organization serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. The company has a market capitalization of $2.94 billion and currently trades at $85.47, which InvestingPro analysis suggests is undervalued relative to its Fair Value estimate. Goldman Sachs (GS) served as financial advisor to Integer, while Willkie Farr & Gallagher advised Irenic.

Read the article

3/12/2026

DOMA Perpetual Capital Management LLC Pushes Pacira BioSciences to Sell Itself

San Francisco Business Journal (03/12/26) Leuty, Ron

Calling spending by Pacira BioSciences Inc.'s (NASDAQ: PCRX) board "wasteful and unjustified," a hedge fund Wednesday called on fellow investors to elect three of its handpicked nominees that could lead to the company's sale. The move by DOMA Perpetual Capital Management LLC amps up a monthslong fight between the Miami asset management firm and Brisbane-based Pacira, a pain-treatment company that last year booked close to three-quarters of a billion dollars in revenue. Pacira hasn't yet announced the date of its annual shareholder meeting, but the proxy fight over the coming months is part of an on-again/off-again trend by biotech investors to wring money or control out of companies with a steady flow of revenue and solid cash reserves. The bottom line, DOMA said Wednesday, is that Pacira's board should work with bankers to sell the company, halt acquisitions of pipeline drugs and return capital to shareholders. "DOMA's aim is to generate profit for the company's shareholders, who have been forced to weather consistent year-over-year declines in the stock price while company expenses and management compensation have soared," according to the firm, which is led by Pedro Escudero. DOMA owns 7.1% of Pacira's outstanding shares. DOMA's board nominees are DOMA Chief Financial Officer Eric de Armas; Christopher Dennis, a psychiatrist with experience in behavioral health, digial health and opioid addiction; and Oliver Benton "Ben" Curtis III, a former federal prosecutor who advises on regulatory enforcement, internal investigations and more. Pacira leaders have met 12 times with DOMA, they said Wednesday, but the firm "has not provided any new insights regarding our strategy or operations that the company and the board are not already carefully evaluating and executing" as part of strategy it calls "5x30." That is a five-point plan targeting goals for 2030, including treating 3 million people with its products annually by the end of this decade. Pacira, led since early 2024 by former Genentech Inc. and Forma Therapeutics executive Frank Lee, has sold the injected, long-acting, nonopioid local anesthetic Exparel since its approval in April 2012. It was responsible for nearly 80% of Pacira's total revenue of $726.4 million last year. But that's just part of the 829-employee company's story. It bought Flexion Therapeutics in late 2021, adding the osteoarthritis treatment Zilretta, and by buying MyoScience Inc. in 2019 it added Iovera, a Food and Drug Administration-cleared handheld device that uses cold temperature to temporarily block nerve signals for up to three months. Its experimental gene therapy PCRX-201 is in a late-stage clinical trial to treat osteoarthritis of the knee as part of a push to develop more genetic medicines and it has a number of drugs in preclinical development, including one for osteoarthritis in dogs. The company has moved to cut costs and return cash to shareholders. For example, it decommissioned a 45-liter Exparel batch manufacturing suite in San Diego, leading to 71 layoffs last year, in favor of two 200-liter suites in San Diego and the United Kingdom. And it said it repurchased $150 million in stock, reducing its outstanding shares from 47 million to 41 million. But the heart of Pacira, which had $238.4 million in cash, equivalents and investments at the end of last year, is Exparel, and DOMA said has been "undermined by management's strategic and operational execution." The company faces competition from a generic version of the drug, which was approved by the FDA in August 2024.

Read the article

3/12/2026

NFL's Travis Kelce Named Six Flags Brand Ambassador as Property Portfolio Shrinks

CoStar (03/12/26) Carlisle, Candace

NFL star Travis Kelce is partnering with Six Flags Entertainment Corp. (NYSE: FUN) to serve as a brand ambassador for the amusement park giant as it readies to shrink its portfolio. This is the first time Six Flags has solidified its relationship with the Kansas City tight end and three-time Super Bowl champion since Kelce teamed up with Jana Partners less than six months ago in hopes of boosting Six Flags' stock. Kelce will be working with Six Flags, the largest regional amusement park operator in North America, "as it enters its next chapter," he said in a statement. "The Six Flags team is creating even more rides and attractions as it takes guest engagement to a new level." The new partnership between Six Flags and Kelce is expected to include marketing support for the company's parks over the course of 2026. The deal includes Kelce supplying digital content across a variety of social media platforms and gives Six Flags the ability to use his name, image and likeness in broadcast media, in-park marketing and streaming platforms. Kelce brings his lifelong fandom of Six Flags to what is expected to soon be a reduced real estate portfolio for the amusement park giant after it struck a $331 million deal with real estate investment trust EPR Properties last week to sell seven of its parks. Six Flags' real estate portfolio is expected to span 34 parks in 23 North American sites for the 2026 season after the deal closes by the end of the second quarter. Charlotte, North Carolina-based Six Flags has struggled with lower attendance at its parks and rising debt totaling more than $5.1 billion, the firm told investors last month. Six Flags' new President and CEO, John Reilly, is seeking to right the business.

Read the article

3/11/2026

Green Investors Threaten BP with Legal Action Over Rejected Resolution

Financial Times (03/11/26) Mooney, Attracta

BP (NYSE: BP) is facing a threat of legal action from climate investors who have accused the energy group of “an unprecedented attack on shareholder rights” over its refusal to include a resolution they filed for next month’s annual meeting. The proposal calling on the company to set out strategies for maintaining shareholder value if oil and gas demand declines was filed in January by 16 institutional investors and a group of retail shareholders brought together by FollowThis, a Dutch green investor group. Corporate governance experts told the FT they were unaware of any previous examples of FTSE 100 companies rejecting resolutions that met filing thresholds — as the FollowThis resolution did. The tussle with BP is the second fight FollowThis has had with a big oil and gas company in recent years, and comes after Exxon (NYSE: XOM) sued it in 2024 in a landmark case over environmental, social and governance resolutions. FollowThis Chief Executive Mark van Baal said BP’s move was a sign of how the battle over ESG and shareholder rights was spreading to Europe from the United States, where there has been a crackdown on shareholder resolutions in recent years. “BP is trying to silence its own shareholders rather than answering them,” he said, adding that the company’s refusal to allow the resolution to be voted on at the annual meeting was “an attack on shareholder rights." "This is unprecedented in the UK as far as we know,” he said. “It would have huge implications if BP can get away with it, because then every company can get away with it." A similar resolution at Shell (NYSE: SHEL) had been accepted, van Baal said. FollowThis has filed resolutions at oil companies for years, including six times at BP, where more than a fifth of shareholders backed its 2021 resolution asking for ambitious climate targets. BP, which last year announced a “strategy reset” to retreat from renewables to reprioritize fossil fuels, said its board had “determined, having taken legal advice, that the proposed resolution did not conform to legal requirements." It added that it had “a clear strategy with multiyear targets to drive long-term shareholder value across the cycle,” and remained “fully committed to responsible industry-standard climate-related reporting." BP in 2023 said a Follow This resolution calling for the company to align its targets with the Paris climate agreement was unclear and disruptive. While the resolution was included at the AGM, BP said at the time that the board reserved discretion to table or exclude future resolutions “in light of the particular circumstances of the resolution in question." In a five-page letter to BP that was seen by the FT, FollowThis said the board must consider the 2026 resolution “on its own merits." It called on BP to issue a supplementary notice that would include its resolution, warned that failure to do so could result in the investor group seeking “urgent injunctive relief requiring the company to comply.” It also warned of further legal action and said that calling an extraordinary general meeting at the company was another possibility. Suren Gomtsyan, a corporate governance expert and assistant professor at LSE Law School, said he had “never heard of a previous case where a FTSE 100 company rejected a shareholder resolution proposal." Such proposals were “generally quite rare” in FTSE100 companies, he added, pointing out that shareholders submitting a resolution needed to hold 5% of voting shares, or number at least 100. FollowThis’s resolution met the latter requirement, with the group saying BP had confirmed in January that the relevant threshold for a valid submission had been met. There were few grounds to reject a shareholder proposal, Gomtsyan said, but one category was “defamatory, frivolous or vexatious” resolutions. A resolution filed by a group of pension funds and the Australasian Center for Corporate Responsibility that called for BP to justify its surge in upstream oil and gas spending will go to a vote at the April meeting. BP’s board has called for shareholders to reject it. BP also proposed revoking two green resolutions passed by shareholders in 2015 and 2019, including one that called for the company to disclose how its strategy was consistent with the Paris Agreement.

Read the article

3/11/2026

Janus Henderson Rejects Victory Capital Takeover Proposal, Backs Trian Deal

Wall Street Journal (03/11/26) Hart, Connor

Janus Henderson’s (NYSE: JHG) board unanimously rejected an unsolicited takeover proposal from Victory Capital (NASDAQ: VCTR), reaffirming its recommendation that shareholders back a previously disclosed take-private transaction by Nelson Peltz’s Trian Fund Management and venture firm General Catalyst. Victory Capital submitted the proposal last month, offering consideration valued at $57.04 a share, including $30 in cash and a fixed exchange ratio of 0.350 shares of Victory Capital common stock. Janus Henderson said Wednesday the board determined the offer doesn’t constitute a “superior proposal” under the terms of its existing merger agreement, citing significant closing risks and uncertain value. The asset manager said it is uncertain it could obtain the required client consents representing 75% of revenue run rate, citing feedback from clients who indicated they would have reservations about maintaining their relationships with Janus Henderson under Victory ownership. The board also said the transaction could struggle to secure shareholder approval and questioned Victory’s estimate of $500 million in potential synergies, saying the cost reductions implied by that figure could lead to operational disruption, employee departures, and client outflows. Trian and General Catalyst said Wednesday that they remain committed to completing their previously announced all-cash acquisition of Janus Henderson and support the board’s decision to reject the competing proposal. The firms said their $49-a-share deal provides shareholders with “immediate and certain value” and that it is progressing toward an expected closing in mid-2026.

Read the article